• Je něco špatně v tomto záznamu ?

Pokroky ve vývoji vakcín proti HIV, tuberkulóze a malárii
[Advances in development of vaccines against HIV, tuberculosis and malaria]

Petra Grznárová, Jan Lipov

. 2010 ; 104 (11) : 1006-1014.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10036077

The research in vaccine development is growing very intensively. More than 95 clinical trials of potential HIV vaccines have been performed in last 25 years. Currently, only two HIV vaccine candidates are in Phase III trials and one in Phase II trial. Tuberculosis is another problematic disease of the 21st century. Calmette-Guérin vaccine from Mycobacterium bovis bacillus is the only one used for immunization against tuberculosis. Unfortunately, it is effective only in newborns but not in adults; thus, efforts are still put to prepare an effective vaccine for immunization and treatment of adults. Malaria killed more than 1 million people in 2006, most of them were children. We still do not have any vaccine effective in prevention of malaria; nevertheless, some vaccine candidates appeared and are now in Phase I or Phase II trial.

Advances in development of vaccines against HIV, tuberculosis and malaria

Bibliografie atd.

Lit.: 73

000      
00000naa 2200000 a 4500
001      
bmc10036077
003      
CZ-PrNML
005      
20111210200759.0
008      
110108s2010 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Grznárová, Petra $7 xx0125837
245    10
$a Pokroky ve vývoji vakcín proti HIV, tuberkulóze a malárii / $c Petra Grznárová, Jan Lipov
246    11
$a Advances in development of vaccines against HIV, tuberculosis and malaria
314    __
$a Ústav biochemie a mikrobiologie, Vysoká škola chemickotechnologická v Praze, Technická 3, 166 28 Praha 6
504    __
$a Lit.: 73
520    9_
$a The research in vaccine development is growing very intensively. More than 95 clinical trials of potential HIV vaccines have been performed in last 25 years. Currently, only two HIV vaccine candidates are in Phase III trials and one in Phase II trial. Tuberculosis is another problematic disease of the 21st century. Calmette-Guérin vaccine from Mycobacterium bovis bacillus is the only one used for immunization against tuberculosis. Unfortunately, it is effective only in newborns but not in adults; thus, efforts are still put to prepare an effective vaccine for immunization and treatment of adults. Malaria killed more than 1 million people in 2006, most of them were children. We still do not have any vaccine effective in prevention of malaria; nevertheless, some vaccine candidates appeared and are now in Phase I or Phase II trial.
650    _2
$a vakcíny proti AIDS $x farmakokinetika $x farmakologie $7 D016915
650    _2
$a vakcíny proti tuberkulóze $x farmakokinetika $x farmakologie $7 D032581
650    _2
$a vakcína proti malárii $x farmakokinetika $x farmakologie $7 D017780
650    _2
$a financování organizované $7 D005381
700    1_
$a Lipov, Jan, $d 1976- $7 xx0125836
773    0_
$w MED00011010 $t Chemické listy $g Roč. 104, č. 11 (2010), s. 1006-1014 $x 0009-2770
856    41
$u http://www.chemicke-listy.cz/docs/full/2010_11_1006-1014.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 1918 $c 395 $y 7
990    __
$a 20110107144915 $b ABA008
991    __
$a 20110110091816 $b ABA008
999    __
$a ok $b bmc $g 824823 $s 689989
BAS    __
$a 3
BMC    __
$a 2010 $b 104 $c 11 $m Chemické listy $x MED00011010 $d 1006-1014
LZP    __
$a 2011-02/vtmv

Najít záznam